5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.34▲ | 1.33▲ | 1.33▲ | 1.39▼ | 1.55▼ |
MA10 | 1.33▲ | 1.33▲ | 1.33▲ | 1.62▼ | 1.77▼ |
MA20 | 1.33▲ | 1.36▼ | 1.37▼ | 1.62▼ | 2.29▼ |
MA50 | 1.37▼ | 1.44▼ | 1.56▼ | 1.88▼ | 2.25▼ |
MA100 | 1.41▼ | 1.63▼ | 1.62▼ | 2.32▼ | 2.74▼ |
MA200 | 1.62▼ | 1.62▼ | 1.66▼ | 2.26▼ | 7.56▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.007▲ | 0.008▲ | 0.011▲ | -0.029▼ | -0.118▼ |
RSI | 52.147▲ | 44.370▼ | 40.315▼ | 33.682▼ | 35.653▼ |
STOCH | 95.000▲ | 75.321 | 59.909 | 26.161 | 9.656▼ |
WILL %R | 0.000▲ | -7.692▲ | -62.500 | -90.318▼ | -95.808▼ |
CCI | 88.614 | 58.333 | -1.264 | -104.673▼ | -106.572▼ |
▼ MACD | $VYNE MACD(12,26,9) Crossed Below Signal Line | Set Alert |
Friday, April 25, 2025 08:56 AM
The U.S. Food and Drug Administration (FDA) on Friday verbally informed that it placed a clinical hold on VYNE Therapeutics Inc.’s (NASDAQ:VYNE) Phase 1b study evaluating VYN202 for the treatment of ...
|
Friday, April 25, 2025 08:03 AM
VYNE Therapeutics Inc. (Nasdaq: VYNE) ("VYNE" or the "Company") today announced that the U.S. Food and Drug Administration (FDA) verbally informed ...
|
Friday, April 25, 2025 07:48 AM
Currently, VYNE is trading at $1.39 down by 25.89 percent on the Nasdaq. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
01/05/25 | 1.32 | 1.35 | 1.29 | 1.34 | 96,839 |
30/04/25 | 1.40 | 1.40 | 1.27 | 1.33 | 395,400 |
29/04/25 | 1.43 | 1.47 | 1.40 | 1.40 | 159,307 |
28/04/25 | 1.45 | 1.54 | 1.36 | 1.44 | 212,700 |
25/04/25 | 1.46 | 1.50 | 1.28 | 1.43 | 1,667,800 |
24/04/25 | 1.993 | 1.993 | 1.83 | 1.88 | 121,800 |
23/04/25 | 1.90 | 1.98 | 1.83 | 1.84 | 60,200 |
22/04/25 | 1.82 | 1.89 | 1.77 | 1.86 | 131,000 |
21/04/25 | 1.84 | 1.88 | 1.75 | 1.79 | 59,400 |
17/04/25 | 1.80 | 1.89 | 1.80 | 1.85 | 79,300 |
|
|
||||
|
|
||||
|
|